SLX 2.67% $5.11 silex systems limited

Nuclear Power Related Media Thread, page-5284

  1. 3,297 Posts.
    lightbulb Created with Sketch. 369
    Hey moosey

    I appreciate and always enjoy reading your research

    I have been interested in and researching the possibilities for Silex Medical isotope enrichment and in
    particular the possible partnerships or joint ventures.

    This has led me to an Australian company TLX Telix Pharmaceuticals Limited. Home - Telix Pharmaceuticals

    Telix is a commercial-stage biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (‘theranostic’) radiopharmaceuticals.Telix’s extensive pipeline for urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma) and bone marrow conditioning is underpinned by a strong global supply, manufacturing and distribution network.Telix has received global regulatory approvals from the Australian Therapeutic Goods Administration (TGA), the U.S. Food and Drug Administration (FDA), and Health Canada for its prostate cancer imaging agent and has more than 18 clinical trials underway worldwide.

    Telix Announces Completion of A$650 Million Convertible Bonds

    In addition, the funding will provide financial flexibility for Telix to explore opportunities and potentially
    pursue strategically significant M&A transactions and continued investment in global supply chain
    and manufacturing capabilities.

    ASX Announcements - Telix Pharmaceuticals

    It could be very beneficial for both these companies to work together.
 
watchlist Created with Sketch. Add SLX (ASX) to my watchlist
(20min delay)
Last
$5.11
Change
-0.140(2.67%)
Mkt cap ! $1.212B
Open High Low Value Volume
$5.02 $5.15 $5.02 $1.256M 246.7K

Buyers (Bids)

No. Vol. Price($)
1 1427 $5.11
 

Sellers (Offers)

Price($) Vol. No.
$5.14 2500 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
SLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.